
Engage with Us
Our Customer Experience Team is your
first point of contact for all inquiries

-General Information – Get answers to your questions about ONWARD products and services.
-Connecting with a Therapy Consultant – Learn more about purchasing ARCEX for your clinic.
-Post-Sale Product Support – Troubleshooting, replacements, and general assistance.
-Product Availability & Marketing Updates – Stay informed about our technologies and therapies.
-Clinical Trial Interest – Learn about ongoing research opportunities.
Submit your request via our webform.
Our team will review your inquiry and respond as soon as possible.
The ARCEX System is now available for purchase. Fill out the form above to learn more.
Visit our Locations
ONWARD Medical is headquartered in Eindhoven, the Netherlands. We maintain a Science and Engineering Center in Lausanne, Switzerland and have a growing US presence in Boston, USA.
For additional corporate information, visit our Investor Relations website
The ONWARD® Medical ARCEX® System is FDA cleared for use in the United States and CE marked in accordance with EU Medical Device Regulation 2017/745. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
Indication for Use (US): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old who present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).
Indication for Use (EU): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).